drugset / Trial / NCT02371031

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

NCT02371031 ↗

Phase 1 Terminated 11 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelDiagnostic

Summary

This is a pilot study designed to evaluate the potential of using FDOPA-PET/MRI for improving surgical planning and providing non-invasive prognostic information in patients with gliomas that have substantial non-enhancing regions. The results will be used to develop larger adequately powered studies.

Timeline

Start
2015-03
Primary completion
2016-07
Completion
2016-07

Outcome

Outcome not reported

Stopped (Business): “Funding source for study ended.”

Drugs

EvaluationDrugModalityDoseRoute
Subject 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine Diagnostic / imaging agent — —

Indications